MORE ABOUT PRESCRIPTION DRUG ABUSE REDUCTION
Since launching our prescription drug abuse reduction strategy in May 2013, we have worked with our strategic partners to address four key objectives to implement our program. In January 2014, CHMI launched the Employee Health Improvement Framework that includes first-of-its-kind best practice guidance on implementing policy and practice changes on behavioral/mental health and wellness that includes addressing substance abuse. Shortly thereafter, with the help of Facebook and MTV, CHMI and the Jed Foundation launched the Jed and Clinton Health Matters College Campus Program, which aims to make college campuses safer and healthier by building their capacity to support the mental and physical needs of their students. As drug abuse by college students continues to increase, we have placed a strong focus on building the capacity of college campuses to support student health and prevent substance abuse.
In April 2014, CHMI hosted a working meeting, in which the FDA and key stakeholders in government, industry, and community groups met to create the initial deliverable plan for expanding Naloxone access in state and communities. This plan includes providing a predictably affordable supply of Naloxone to community groups; creating a window of opportunity for the Naloxone distribution field to scale over the next four years; expanding continuing medical education on Naloxone, targeting doctors and health workers; and rigorous implementation of community-based distribution and access efforts. CHMI is addressing our final objective of medical education by creating new continuous medical education courses specific to prevention of use by young adults with Medscape and the Jed Foundation. By taking the lead and continuing research in this field, CHMI and its partners will continue to create innovative ways to reach our final goal: cutting prescription drug abuse deaths in half and saving approximately 10,000 lives.